is retatrutide a glp-1 drug for weight loss: Study shows 30% body weight loss new glp 1 drug retatrutide

The researchers said thats a trend which may continue in subsequent years. While dyskinesia, or involuntary muscle movements, were the most targeted symptom, there also appeared to be an increase in trials targeting nonmotor Parkinsons symptoms such as cognition, depression, or psychosis, the report found

Rybelsus (semaglutide) EMA Product Information (PDF)

That refers to how well patients handle the drug a key metric in trials on medicines containing GLP-1s, which often bring gastrointestinal side effects

(Bejing Peptide) ZT002 injection was approved by the Australian Human Research Ethics Committee for Phase I clinical trials